Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol EC-FV-01: A Phase 1 Study of EC145 Administered in Weeks 1 and 3 of a 4-Week Cycle

NCT00308269 is registered in ClinicalTrials.gov with Endocyte as lead sponsor.

NCT NCT00308269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00308269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol EC-FV-01: A Phase 1 Study of EC145 Administered in Weeks 1 and 3 of a 4-Week Cycle
Lead sponsor
Endocyte
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2006
Completion date
July 31, 2008
Enrollment
32 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer